LFCR Lifecore Biomedical, Inc.

NASDAQ
$4.72

Lifecore Biomedical, Inc. (LFCR) Earnings News

Earnings press releases and Earnings Whispers previews for Lifecore Biomedical, Inc. (LFCR), newest first.

Wednesday August 5, 2026 7:05 AM ET
Lifecore Biomedical Reports Financial Results for the Second Quarter Ended June 30, 2026, and Provides Corporate Update
Wednesday July 29, 2026 4:05 PM ET
Lifecore Biomedical to Report Financial Results for the Second Quarter Ended June 30, 2026, on August 5, 2026
Monday June 15, 2026 7:05 AM ET
Lifecore Biomedical Signs New Agreement with Global Pharmaceutical Company
Tuesday June 2, 2026 7:05 AM ET
Lifecore Biomedical Signs Agreement with New Biopharmaceutical Customer
Wednesday May 6, 2026 7:05 AM ET
Lifecore Biomedical Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate Update
Wednesday April 29, 2026 4:05 PM ET
Lifecore Biomedical to Report Financial Results for the First Quarter Ended March 31, 2026, on May 6, 2026
Thursday March 26, 2026 7:00 AM ET
Lifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical Customer
Monday March 23, 2026 7:00 AM ET
Lifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics Company
Monday March 16, 2026 8:00 AM ET
Lifecore Biomedical Reports Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, and Provides Corporate Update
Monday March 9, 2026 4:05 PM ET
Lifecore Biomedical to Report Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, on March 16, 2026
Wednesday March 4, 2026 4:03 PM ET
Lifecore Biomedical Signs New Agreement with Indomo to Support Innovative Drug/Device Combination Acne Treatment